Facial Plast Surg 2020; 36(02): 194-199
DOI: 10.1055/s-0040-1709130
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Quality of Life Studies in Skin Cancer Treatment and Reconstruction

Authors

  • Andrew William Joseph

    1   Department of Otolaryngology—Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan
Further Information

Publication History

Publication Date:
15 May 2020 (online)

Abstract

Health-related quality of life (HRQOL) is an important measure of patient experience before, during, and after treatment for skin cancers. Over the past 20 years, a variety of generic as well as disease-specific HRQOL instruments have been developed to assess clinical outcomes. Clinical trials have increasingly focused on using HRQOL instruments as outcome measures. Patients with both cutaneous melanoma and nonmelanotic skin cancers have been found to experience improvement in HRQOL following surgical treatment and reconstruction. Individual demographic variables may further predict experience within each of these groups. Increasing use of HRQOL instruments in future studies comparing skin cancer treatments will allow physicians to better understand and optimize patient experiences.